Nexalis Therapeutics Ltd Sustainability Reports
Nexalis Therapeutics Limited is a clinical-stage biotechnology company that develops drug-device combinations. Its pipeline focuses on rapid-onset therapies for the treatment of pain and mental health disorders.
Sector: Manufacturing
Country: Australia
Exchange: Australian Securities Exchange
2 reports from 2022 to 2023
Company Profile
Nexalis Therapeutics Limited is a clinical-stage biotechnology company that develops drug-device combinations. Its pipeline focuses on rapid-onset therapies for the treatment of pain and mental health disorders.
Reports
2 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
